Drug Type Small molecule drug |
Synonyms Factor B-IN-5 |
Target |
Action inhibitors |
Mechanism CFB inhibitors(Complement factor B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC27H32N2O4 |
InChIKeyYJJUEZFALZMWAP-URXFXBBRSA-N |
CAS Registry2797066-85-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Discovery | - | 07 Aug 2020 |